Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo

Hepatology

Volumn 27, Issue 1, 1998, Pages 73-80

  Yin, L ^a   Ghebranious, N ^a   Chakraborty, S ^a   Sheehan, C E ^a   Ilic, Z ^a   Sell, S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA TEMPLATE; GENE MUTATION; IN VIVO STUDY; LIVER CELL; MOUSE; NONHUMAN; PLOIDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS GENOME; VIRUS INFECTION;

EID: 0031983150     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270113     Document Type: Article

References (53)

1. 1 Nelson WG, Kastan MB. DNA strand breaks: the DNA template alterations that trigger p53‐dependent DNA damage responsive pathways. Mol Cell Biol 1994 ; 14: 1815–1823. MEDLINE
2. 2 Zhan Q, Bae I, Kastan MB, Fornace AJ. The p53‐dependent gamma‐ray response of GADD45. Cancer Res 1994 ; 54: 2755–2760. MEDLINE
3. 3 El‐Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, et al. WAF1/CIP1 is induced in p53‐mediated G1 arrest and apoptosis. Cancer Res 1994 ; 54: 1169–1174. MEDLINE
4. 4 Smith ML, Chen IT, Zhan Q, Bae I, Che C‐Y, Gilmer MT, Kastan MB, et al. Interaction of the p53‐regulated protein GADD45 with proliferating cell nuclear antigen. Science 1994 ; 266: 1376–1380. MEDLINE
5. 5 Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin‐dependent kinases controls DNA replication by interaction with PCNA. Nature 1994 ; 369: 574–578. MEDLINE
6. 6 Kastan MB, Onyekwene O, Sidransky D, Voglestein B, Craig BW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991 ; 51: 6304–6311. MEDLINE
7. 7 Dutta A, Ruppert JM, Aster JC, Winchester E. Inhibition of DNA replication factor RPA by p53. Nature 1993 ; 365: 79–82. MEDLINE
8. 8 Waga S, Stillman B. Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature 1994 ; 369: 207–212. MEDLINE
9. 9 Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wylie AH. Thymocyte apoptosis induced by p53‐dependent and independent pathways. Nature 1993 ; 362: 849–852. MEDLINE
10. 10 Lowe SW, Schmiff EM, Smith SW, Osborne BA, Jacks T. P53 is regulated for radiation‐induced apoptosis in mouse thymocytes. Nature 1993 ; 362: 847–849. MEDLINE
11. 11 Lowe SW, Ruley HE, Jacks T, Housman DE. P53‐mediated apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993 ; 74: 957–967. MEDLINE
12. 12 Lee JM, Bernstein A. Apoptosis, cancer and the p53 tumor suppressor gene. Cancer Metastasis Rev 1995 ; 14: 149–161. MEDLINE
13. 13 Hartwell LH. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 1992 ; 71: 543–546. MEDLINE
14. 14 Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994 ; 266: 1821–1828. MEDLINE
15. 15 Hollstein M, Sidransky D, Rogelstein B, Harris CC. P53 mutations in human cancers. Science 1991 ; 253: 49–53. MEDLINE
16. 16 Levine AJ, Monand J, Finlay A. The p53 tumor suppressor gene. Nature 1991 ; 351: 453–456. MEDLINE
17. 17 Caron de Fromentel C, Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosom Cancer 1992 ; 4: 1–15. MEDLINE
18. 18 Ozturk M. P53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991 ; 338: 1356–1359. MEDLINE
19. 19 Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from Southern Africa. Nature 1991 ; 350: 429–431. MEDLINE
20. 20 Agular F, Harris CC, Sun T, Hollstein B, Cerutti P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 1994 ; 264: 1317–1319. MEDLINE
21. 21 Ghebranious N, Knoll BJ, Wu H, Lozano G, Sell S. Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure. Mol Carcinog 1995 ; 13: 104–111. MEDLINE
22. 22 Dunenio L, Oguey D, Wu J, Messier N, Fausto N. Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation. Hepatology 1995 ; 22: 1279–1288. MEDLINE
23. 23 Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Burel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992 ; 356: 215–221. MEDLINE
24. 24 Seglen PO. Preparation of rat liver cells. Exp Cell Res 1973 ; 82: 319–398. MEDLINE
25. 25 Yavorkovsky L, Lai E, Ilic Z, Sell S. Participation of small intraportal stem cells in the restitutive response of the liver of periportal necrosis induced by allyl alcohol. Hepatology 1995 ; 21: 1702–1712. MEDLINE
26. 26 Becus JW, Garce LJ. Optical microscope system for standardized cell measurement and analysis. Appl Optics 1987 ; 26: 3280–3293.
27. 27 Shima A, Sugahara T. Age‐dependent ploidy class changes in mouse hepatocytes nuclei as revealed by Feulgen‐DNA cytofluorometry. Exp Gerontol 1976 ; 11: 193–203. MEDLINE
28. 28 Ohtsubo, Nomaguchi TA. A flow cytofluorometric study on age‐dependent ploidy class changes in mouse hepatocyte nuclei. Mech Ageing Dev 1986 ; 36: 125–131. MEDLINE
29. 29 Zajicek G, Schwartz‐Arad D, Bartfild E. The streaming liver. V: Time and age‐dependent changes of hepatocyte DNA content, following partial hepatectomy. Liver 1989 ; 9: 164–171. MEDLINE
30. 30 Kudryavtsev BN, Kudryavtseva MV, Sakuta GA, Stein GI. Human hepatocyte polyploidization kinetics in the course of life cycle. Virchows Arch B Cell Pathol Incl Mol Pathol 1993 ; 64: 387–393. MEDLINE
31. 31 Bucher NLR, Malt RA. Regeneration of the Liver and Kidney. Boston: Little, Brown and Co. 1971.
32. 32 Almendral JM, Huebsch D, Blundell PA, Macdonald‐Bravo R. Cloning and sequence of the human nuclear protein cyclin: homology with DNA‐binding proteins. Proc Natl Acad Sci USA 1987 ; 84: 1575–1579. MEDLINE
33. 33 Bravo R, Frank R, Blundell PA, MacDonald‐Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase. Nature 1987 ; 326: 515–517. MEDLINE
34. 34 Prelich G, Cheng‐Keat T, Kostura M, Mathew MB, So AG, Downey KM, Stillman B. Functional identity of proliferating cell nuclear antigen and a DNA polymerase auxiliary protein. Nature 1987 ; 326: 517–520. MEDLINE
35. 35 Fairman MP. DNA polymerase/PCNA: actions and interactions. J Cell Sci 1990 ; 95: 1–4. MEDLINE
36. 36 Kuki P, Vanderlaan NM, Dolbeare F, Gray J, Tan EM. Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 1986 ; 166: 209–219. MEDLINE
37. 37 Rao PS, Dalu A, Kulkarni SG, Mehendale HM. Stimulated tissue repair prevents lethality in isopropanol‐induced potentiation of carbon tetrachloride hepatotoxicity. Toxicol Appl Pharmacol 1996 ; 140: 235–244. MEDLINE
38. 38 Yahanda AM, Bruner JM, Donehower LA, Morrison RS. Astrocytes derived from p53‐deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol 1995 ; 15: 4249–4259. MEDLINE
39. 39 Tsukada T, Tomooka Y, Takai S, Veda Y, Nishikawa S, Yagi T, Tokunaga T, et al. Enhanced proliferative potential in culture of cells from p53‐deficient mice. Oncogene 1993 ; 8: 3313–3322. MEDLINE
40. 40 Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin‐dependent kinases. Genes Dev 1995 ; 9: 1149–1163. MEDLINE
41. 41 Link SP, Clarkin KC, Dileonardo A, Tsou A, Wahl M. A reversible, p53‐dependent G 0 /G 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev 1996 ; 10: 934–947. MEDLINE
42. 42 Nakanishi M, Adami GR, Robetroye RS, Noda A, Venable SF, Dimitrov D, Pereira‐Smith OM, Smith JR. Exit from G 0 and entry into the cell cycle of cells expressing p21 antisense RNA. Proc Natl Acad Sci USA 1995 ; 92: 4352–4356. MEDLINE
43. 43 Winey M. Keeping the centrosome cycle on track. Genome stability. Curr Biol 1996 ; 6: 962–964. MEDLINE
44. 44 Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH, Reid BJ. A p53‐dependent mouse spindle checkpoint. Science 1995 ; 267: 1353–1356. MEDLINE
45. 45 Geyp M, Ireland CM, Pittman SM. Increased tubulin acetylation accompanies reversion to stable ploidy in vincristine‐resistant CCRF‐CEM cells. Cancer Genet Cytogenet 1996 ; 87: 116–122. MEDLINE
46. 46 Di Leonardo A, Khan SH, Linke SP, Greco V, Seidita G, Wahl GM. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res 1997 ; 57: 1013–1019. MEDLINE
47. 47 Wu H, Wade M, Krall L, Grisham J, Xiong Y, Ryke TV. Targeted in vivo expression of the cyclin‐dependent kinase inhibitor p21 halts hepatocyte cell cycle progression, postnatal liver development, and regeneration. Genes Dev 1996 ; 10: 245–260. MEDLINE
48. 48 Khaonstov VL, Ozer A, Smith JR, Noda A, Mearns M, Krishman B, Slagle BZ, Yoffe B. Induction of senescent cell‐derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (Hep G2) cells arrested in the G2‐phase of the cell cycle by 9‐Nitrocamptochecin. Lab Invest 1995 ; 72: 118–127.
49. 49 Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda R, Raskind WH, Reid BJ. A p53‐dependent mouse spindle checkpoint. Science 1995 ; 267: 1353–1356. MEDLINE
50. 50 Harvey M, Sands ST, Weiss RS, Hegi ME, Wiseman RW, Rantazis P, Giovanella BC, et al. In vivo growth characteristics of embryofibroblasts from p53‐deficient mice. Oncogene 1993 ; 8: 2457–2467. MEDLINE
51. 51 Bellamy COC, Clarke AR, Wyllie AH, Harrison DJ. P53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J 1997 ; 11: 591–599. MEDLINE
52. 52 Ryan JJ, Danish R, Gottlieb CA, Clark MF. Cell cycle analysis of p53‐induced cell death in murine erythro‐leukemia cells. Mol Cell Biol 1993 ; 13: 711–719. MEDLINE
53. 53 Leonard CJ, Canman CE, Kastan MB. The role of p53 in cell‐cycle control and apoptosis: implications for cancer 3. In: Hellman, S Rosenberg, SA eds. Important Advances in Oncology. Lippincott: Philadelphia. 1995 ; 33–42.